Varaico: Literature-Extracted Genetic Variants

Gene:GLA
Variant:p.K213_P214Splc
Back to variants list

GLA

NM_000169.3:p.K213_P214Splc

Associated Papers

Oxford Nanopore Technologies [ONT] Sequencing: Clinical Validation in Genetically Heterogeneous Disorders.

Urtis M et al.

Genes, 2025

41300778 (PubMed )
Supplement: genes-16-01325-s001.zip › genes-3897287-supplementary.pdf

Long-read sequencing enables comprehensive molecular genetic diagnosis of Fabry disease.

Yao F et al.

Human Genomics, 2024

Regulating PCCA gene expression by modulation of pseudoexon splicing patterns to rescue enzyme activity in propionic acidemia.

Spangsberg Petersen US et al.

Molecular Therapy. Nucleic Acids, 2024

38204914 (PubMed )
Supplement: mmc2.pdf

All reported non-canonical splice site variants in GLA cause aberrant splicing.

Okada E et al.

Clinical and Experimental Nephrology, 2023

Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease.

Dai X et al.

Orphanet Journal of Rare Diseases, 2022

Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.

Petersen USS et al.

Human Mutation, 2022

Corrigendum: Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Keegan NP et al.

Frontiers in Genetics, 2022

35754842 (PubMed )
Supplement: DataSheet1.xlsx › Table_S3

Precision Medicine through Next-Generation Sequencing in Inherited Eye Diseases in a Korean Cohort.

Moon D et al.

Genes, 2021

35052368 (PubMed )
Supplement: genes-13-00027-s001.zip › genes-1495226-supplementary.pdf

Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Keegan NP et al.

Frontiers in Genetics, 2021

Oxidative stress biomarkers in Fabry disease: is there a room for them?

Simoncini C et al.

Journal of Neurology, 2020

GLA missense and promoter variants co-segregating in a Chinese family with Fabry disease.

Dong ZY et al.

Annals of Translational Medicine, 2020

Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ.

Ferri L et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry, 2018

Impact, Characterization, and Rescue of Pre-mRNA Splicing Mutations in Lysosomal Storage Disorders.

Dardis A et al.

Genes, 2018

Previously Unreported in Women Galactosidase Alpha Pro409Ser Variant Is Associated With Fabry Disease.

Luis SA et al.

Circulation. Cardiovascular Genetics, 2017

Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations.

Ferri L et al.

Molecular Therapy. Nucleic Acids, 2016

Klinefelter syndrome with fabry disease--a case of nondisjunction of the X-chromosome with sex-linked recessive mutation.

Sadick VJ et al.

Heart, Lung & Circulation, 2014

Cognitive and psychological functioning in Fabry disease.

Sigmundsdottir L et al.

Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists, 2014

Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene.

Ferri L et al.

Clinical Genetics, 2012

Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group.

Gal A et al.

Journal of Inherited Metabolic Disease, 2011

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."